ALLYSON WILLIAMS: Open Payments
NPI 1407115579 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$840 in 29 payments from 13 companies in 2025. Trend: 2023 $1,673 · 2024 $1,719 · 2025 $840
Food & beverage: $840
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $169 |
| Alkermes, Inc. | 2 | $156 |
| Vanda Pharmaceuticals Inc. | 7 | $150 |
| Teva Pharmaceuticals USA, Inc. | 4 | $144 |
| Neurocrine BioSciences, Inc. | 2 | $57 |
| HARMONY BIOSCIENCES LLC | 1 | $35 |
| Lundbeck LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $19 |
| ABBVIE INC. | 1 | $19 |
Products named: REXULTI, LYBALVI, UZEDY, FANAPT, HETLIOZ, INGREZZA, AUSTEDO XR, WAKIX.
Industry payments across TN — which companies pay providers there.
